Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently bought shares of Revvity, Inc. (NYSE:RVTY). In a filing disclosed on March 27th, the Representative disclosed that they had bought between $1,001 and $15,000 in Revvity stock on February 25th. The trade occurred in the Representative’s “JP MORGAN BROKERAGE ACCOUNT” account.
Representative Robert Bresnahan, Jr. also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of Intuit (NASDAQ:INTU) on 3/7/2025.
- Sold $1,001 – $15,000 in shares of Tesla (NASDAQ:TSLA) on 3/6/2025.
- Purchased $1,001 – $15,000 in shares of SEA (NYSE:SE) on 3/5/2025.
- Sold $1,001 – $15,000 in shares of Credo Technology Group (NASDAQ:CRDO) on 3/4/2025.
- Purchased $1,001 – $15,000 in shares of Meta Platforms (NASDAQ:META) on 3/4/2025.
- Purchased $1,001 – $15,000 in shares of Twilio (NYSE:TWLO) on 3/4/2025.
- Sold $15,001 – $50,000 in shares of Alibaba Group (NYSE:BABA) on 3/4/2025.
- Purchased $1,001 – $15,000 in shares of Zoom Video Communications (NASDAQ:ZM) on 3/4/2025.
- Purchased $1,001 – $15,000 in shares of Intel (NASDAQ:INTC) on 3/3/2025.
- Purchased $1,001 – $15,000 in shares of Snowflake (NYSE:SNOW) on 3/3/2025.
Revvity Stock Down 1.6 %
Shares of RVTY stock traded down $1.69 during mid-day trading on Friday, reaching $105.65. 852,250 shares of the company were exchanged, compared to its average volume of 874,547. The company has a market capitalization of $12.69 billion, a P/E ratio of 47.81, a P/E/G ratio of 3.82 and a beta of 1.06. The business’s 50 day simple moving average is $115.16 and its 200 day simple moving average is $117.19. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.03 and a current ratio of 3.60. Revvity, Inc. has a fifty-two week low of $97.32 and a fifty-two week high of $129.50.
Revvity Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Thursday, April 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.27%. Revvity’s dividend payout ratio (DPR) is presently 12.67%.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of RVTY. Assetmark Inc. lifted its holdings in Revvity by 3,700.0% in the fourth quarter. Assetmark Inc. now owns 266 shares of the company’s stock worth $30,000 after purchasing an additional 259 shares during the period. Optiver Holding B.V. acquired a new stake in shares of Revvity in the 4th quarter worth approximately $33,000. Quarry LP boosted its holdings in shares of Revvity by 45.7% in the fourth quarter. Quarry LP now owns 303 shares of the company’s stock valued at $34,000 after acquiring an additional 95 shares in the last quarter. Millstone Evans Group LLC acquired a new position in shares of Revvity during the fourth quarter valued at approximately $38,000. Finally, Vermillion Wealth Management Inc. bought a new stake in Revvity during the fourth quarter worth approximately $41,000. 86.65% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In related news, insider Joel S. Goldberg sold 15,170 shares of Revvity stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $126.73, for a total value of $1,922,494.10. Following the transaction, the insider now directly owns 33,400 shares in the company, valued at $4,232,782. The trade was a 31.23 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Tajinder S. Vohra sold 5,492 shares of the company’s stock in a transaction dated Tuesday, January 7th. The shares were sold at an average price of $116.81, for a total transaction of $641,520.52. Following the sale, the insider now directly owns 19,652 shares of the company’s stock, valued at $2,295,550.12. This represents a 21.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.68% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
RVTY has been the topic of several research analyst reports. KeyCorp raised their price objective on Revvity from $132.00 to $145.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. Sanford C. Bernstein downgraded shares of Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 price target on the stock. in a research report on Friday, January 10th. Raymond James reaffirmed an “outperform” rating and set a $145.00 price objective (up previously from $140.00) on shares of Revvity in a research report on Monday, February 3rd. Barclays raised their target price on shares of Revvity from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Finally, Bank of America raised Revvity from a “neutral” rating to a “buy” rating and set a $138.00 target price for the company in a report on Friday, December 13th. Four analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $136.25.
Get Our Latest Analysis on RVTY
About Representative Bresnahan
Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania’s 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania’s 8th Congressional District. He declared candidacy for the 2026 election.
Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.
About Revvity
Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
See Also
- Five stocks we like better than Revvity
- A Deeper Look at Bid-Ask Spreads
- MarketBeat Week in Review – 03/24 – 03/28
- What Are Earnings Reports?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Stock Analyst Ratings and Canadian Analyst Ratings
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.